Clinical Trial Update: Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase II study evaluating concurrent lenvatinib and radiotherapy for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Hepatocellular Carcinoma, Radiotherapy | Phase 2 | Status: COMPLETED